Trial Profile
Everolimus-Eluting Stent in the Treatment of Bifurcation Lesions: Comparison of Main Vessel Stent to Main Vessel and Side Branch Stent
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Feb 2022
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 24 Jul 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 19 Jun 2009 New trial record